A pharmaceutical executive collapsed beside US President Donald Trump during his Oval Office announcement on new obesity drug price cuts, abruptly halting the live event.

The incident occurred just moments after Trump unveiled a landmark deal with drugmakers Eli Lilly and Novo Nordisk to dramatically lower the price of popular GLP-1 weight-loss medications like Wegovy and Zepbound.

According to the Associated Press, the man -- identified by witnesses as Novo Nordisk executive Gordon Findlay -- lost his balance and fell to the ground. Dr. Mehmet Oz, who now heads the Centres for Medicare & Medicaid Services, rushed forward to assist, preventing the man from hitting his head.

BREAKING: A man just collapsed during President Trump’s Oval Office announcement. Praying for him. pic.twitter.co

See Full Page